Both MAZ and TBK1 silencing significantly decreased the viability and proliferation of thyroid cancer cells, whereas the inhibitory effect was not further enhanced by the cotransfection with MAZ siRNA and TBK1 siRNA (Figure 6C–E). This evidence concerns the gene MAZ and thyroid gland carcinoma.